● Recruiting
Phase II
Oncology
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
What is being tested: Inebilizumab, a monoclonal antibody targeting B cells, is being evaluated for its pharmacokinetics, pharmacodynamics, safety, and tolerability in children with…
05 Oct 2026
NCT06987539